Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3391562 | 0.78 | CHRNA7 (0.50) | CHRNA7 | |
| SCHEMBL19975778 | 0.78 | CHRNA7 (0.50) | CHRNA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL9086131 | 0.75 | ACHE (0.31) | — | |
| Water SCHEMBL20473028 | 0.74 | CHRNA7 (0.47) | CHRNA7 | |
| Bromide SCHEMBL17055042 | 0.64 | CHRNA7 (0.39) | CHRNA7 | |
| SCHEMBL25874159 | 0.61 | CHRNA7 (0.37) | CHRNA7 | |
| SCHEMBL841576 | 0.61 | — | — | |
| Iodide SCHEMBL5146160 | 0.59 | CHRNA7 (0.35) | CHRNA7 | |
| Bromide SCHEMBL1502904 | 0.59 | CHRNA7 (0.35) | CHRNA7 | |
| Hydrochloric Acid SCHEMBL1502874 | 0.59 | CHRNA7 (0.35) | CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4545532-A1 | ADDITIVES FOR IMPROVED C-H FLUORINATION REACTIONS | Universität Regensburg (DE) | 2025-04-30 | — | — | EP | claimed |
| EP-2912011-A1 | PROCESSES AND REAGENTS FOR MAKING DIARYLIODONIUM SALTS | Ground Fluor Pharmaceuticals Inc. (US) | 2015-09-02 | — | — | EP | claimed |
| WO-2014066772-A1 | PROCESSES AND REAGENTS FOR MAKING DIARYLIODONIUM SALTS | Ground Fluor Pharmaceuticals, Inc. (US) | 2014-05-01 | — | — | WO | claimed |
| EP-0478210-B1 | Fluorinated diazabicycloalkane derivatives | AIR PROD & CHEM (US) | 1995-11-15 | — | — | EP | claimed |
| EP-0478210-A1 | Fluorinated diazabicycloalkane derivatives | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1992-04-01 | — | — | EP | claimed |
| US-5086178-A | Fluorinated diazabicycloalkane derivatives | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1992-02-04 | — | — | US | claimed |
| EP-4545532-A1 | ADDITIVES FOR IMPROVED C-H FLUORINATION REACTIONS | Universität Regensburg (DE) | 2025-04-30 | — | — | EP | disclosed |
| EP-2909181-B1 | PKM2 MODULATORS AND METHODS FOR THEIR USE | TOLERO PHARMACEUTICALS INC (US) | 2017-08-09 | — | — | EP | disclosed |
| US-20170015631-A1 | PKM2 MODULATORS AND METHODS FOR THEIR USE | SUMITOMO PHARMA ONCOLOGY, INC. | 2017-01-19 | — | — | US | disclosed |
| US-9394257-B2 | PKM2 modulators and methods for their use | TOLERO PHARMACEUTICALS, INC. (US) | 2016-07-19 | — | — | US | disclosed |
| US-20150344436-A1 | PKM2 MODULATORS AND METHODS FOR THEIR USE | SUMITOMO PHARMA ONCOLOGY, INC. | 2015-12-03 | — | — | US | disclosed |
| US-9174984-B2 | Chemical compounds | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2015-11-03 | — | — | US | disclosed |
| US-20140296204-A1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2014-10-02 | — | — | US | disclosed |
| US-20140234198-A1 | ETCHING METHOD AND METHOD FOR PERFORMING SURFACE PROCESSING ON SOLID MATERIAL FOR SOLAR CELL | DAIKIN INDUSTRIES, LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| WO-2014062838-A2 | PKM2 MODULATORS AND METHODS FOR THEIR USE | TOLERO PHARMACEUTICALS, INC. (US) | 2014-04-24 | — | — | WO | disclosed |
| WO-2013062945-A1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2013-05-02 | — | — | WO | disclosed |
| EP-0478210-B1 | Fluorinated diazabicycloalkane derivatives | AIR PROD & CHEM (US) | 1995-11-15 | — | — | EP | disclosed |
| EP-0478210-A1 | Fluorinated diazabicycloalkane derivatives | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1992-04-01 | — | — | EP | disclosed |
| US-5086178-A | Fluorinated diazabicycloalkane derivatives | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1992-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296204-A1 | CHEMICAL COMPOUNDS | DNMT1, DNMT3A, DNMT3B | CHRNA7 4298/4885 |
| US-20170015631-A1 | PKM2 MODULATORS AND METHODS FOR THEIR USE | PDK1, PDK2, PKM | CHRNA7 3642/4885 |
| US-20150344436-A1 | PKM2 MODULATORS AND METHODS FOR THEIR USE | PDK1, PDK2, PKM | CHRNA7 3642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.